It is correct and usable in written English.
You could use it when describing the results of a research project. For example, "Most studies evaluating the effectiveness of preventative healthcare interventions have shown promising results."
Most studies evaluating effects of cannabis use in young adults are cross-sectional, limiting causal inference.
Most studies evaluating LID performance for mitigating floods focus on the changes of peak flow and runoff volume.
Most studies evaluating antibody detection assays are conducted on samples from healthy blood donors but not on samples of hospitalized patients which can show non-specific reactions.
Most studies evaluating the macroeconomic effects of financial support policies on business-funded R&D use econometric methods that do not consider the existence of spatial effects, and generate biased estimates.
However, most studies evaluating the impacts of B. excelsa seed harvesting investigated only effects in harvested sites, and did not consider B. excelsa availability in the landscape, or patterns of harvesting at broader scales, which are critical to evaluate the viability of extraction and plan management practices.
Most studies evaluating the administration of topical intranasal LA are of poor quality.
However, most studies evaluating patient-reported outcomes do not use a reference population or pre-injury values.
Most studies evaluating defects left after curettage of giant cell tumors take place in the distal femur and proximal tibia, the two most common locations of these tumors [17].
Additionally, the TH-implementation in non-shockable patients is often left at the bedside physician's discretion in most studies evaluating this issue, and important bias should be introduced regarding the correct selection of patients [74, 83].
Most studies evaluating sstr tracers in vivo typically used a rat pancreatic cell model, i.e. AR42J (Froidevaux et al. 2002), or HEK cells transfected with somatostatin receptors (Fani et al. 2012b; Ginj et al. 2006; Fani et al. 2011), which may not adequately represent a breast cancer phenotype.
Notably, studies have shown that treatment with albumin alone is inferior to treatment with other medications in conjunction with albumin; most studies evaluating pre-transplant therapies for HRS involve the use of albumin in conjunction with other medical or procedural treatment.
